Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SLNO Deadline: SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire - 1 hour ago

NEW YORK , April 27, 2026 /PRNewswire/ --

SLNO : 52.75 (+0.06%)
SLNO Deadline: Rosen Law Firm Urges Soleno Therapeutics, Inc. (NASDAQ: SLNO) Stockholders to Contact the Firm for Information About Their Rights Business Wire - Mon Apr 27, 10:37AM CDT

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025...

SLNO : 52.75 (+0.06%)
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline PR Newswire - Fri Apr 24, 9:00PM CDT

NEW YORK and NEW ORLEANS , April 24, 2026 /PRNewswire/ -- Kahn Swick & Foti , LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ...

SLNO : 52.75 (+0.06%)
INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman PR Newswire - Thu Apr 23, 4:46PM CDT

SAN FRANCISCO , April 23, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class...

SLNO : 52.75 (+0.06%)
Are WSR, SLNO, OMEX, AVNS Obtaining Fair Deals for their Shareholders? PR Newswire - Thu Apr 23, 10:43AM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

OMEX : 0.9200 (unch)
AVNS : 24.62 (-0.16%)
WSR : 18.92 (-0.16%)
SLNO : 52.75 (+0.06%)
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Drug Safety Risks: SueWallSt PR Newswire - Thu Apr 23, 8:00AM CDT

Important Notice Regarding Alleged DCCR Safety Data Misrepresentations

SLNO : 52.75 (+0.06%)
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire - Wed Apr 22, 5:15PM CDT

NEW YORK , April 22, 2026 /PRNewswire/ --

SLNO : 52.75 (+0.06%)
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire - Wed Apr 22, 11:00AM CDT

LOS ANGELES , April 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

SLNO : 52.75 (+0.06%)
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Hiding Post-Launch Safety Crisis: Levi & Korsinsky PR Newswire - Wed Apr 22, 8:00AM CDT

From Optimism to Disillusionment: How Investor Sentiment Shifted

SLNO : 52.75 (+0.06%)
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 PR Newswire - Wed Apr 22, 7:02AM CDT

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options

SLNO : 52.75 (+0.06%)

Barchart Exclusives

As Nvidia and Oklo Partner on AI Factories, Should You Buy OKLO Stock? Barchart - 33 minutes ago
Oklo is partnering with Nvidia and Los Alamos National Laboratory to develop nuclear-powered AI factories. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.